Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. A. Wedzicha, A. Agusti, J. Vestbo, J. Kampschulte, D. Singh, P. Frith, D. Dusser, P. Jones (London, Manchester, United Kingdom; Barcelona, Spain; Berlin, Germany; Adelaide, Australia; Paris, France). Late Breaking Abstract: Novel detection of exacerbations of COPD with patient reported outcome (EXACT-PRO) and Blackberry (BB). Eur Respir J 2010; 36: Suppl. 54, 395

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Compare outcomes between COPD patients treated with tiotropium/olodaterol (TIO/OLO) and umeclidium/vilanterol (UMEC/VI) Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Late Breaking Abstract - Prevalence, characterization and costs of severe asthma in Spain (BRAVO 1) Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020 Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract - Compare outcomes between COPD patients treated with Tiotropium/Olodaterol (TIO/OLO) and other fixed-dose LAMA/LABAs Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey. Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 The hospital debut of COPD patients. The "Phenotype and Course of COPD" (PAC-COPD) Study Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS) Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED). Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 LATE-BREAKING ABSTRACT: The development of a Patient Reported Experience Measure in COPD (PREM-COPD Stage 2) Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 Late Breaking Abstract - Adherence to GOLD recommendations in Italian patients with COPD categorised as frequent and non-frequent exacerbators: The MISTRAL study Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG)  in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients. Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 Late Breaking Abstract - Tocilizumab (T) plus pembrolizumab (P) in patients (pts) with Covid-19 pneumonia: COPERNICO Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021